Brazil International Ltd. is a boutique company that provides business
services for companies in the medical device field, seeking to
successfully penetrate and participate in the Brazilian market.
Latest update Brazil Regulations By S. Jaime - Qserve Group (Qserve Conferen...qserveconference2013
The document discusses regulations for medical devices in Brazil, including the country's healthcare system and regulatory approval process. It outlines key steps such as classification, appointing a Brazilian registration holder, ANVISA GMP inspection, INMETRO certification, and ANVISA registration. The lengthy overall process and importance of understanding regulatory changes and working with a local partner are emphasized.
This document provides information about ANVISA, the National Health Surveillance Agency of Brazil. Some key points:
- ANVISA is the regulatory body that oversees pharmaceuticals, cosmetics, medical devices and other health products in Brazil. It was established in 1999.
- ANVISA's mission is to protect and promote public health by ensuring safety and quality standards for products and services.
- It is responsible for monitoring drug prices, medical device approval, tobacco control and more. ANVISA works with the Brazilian Ministry of Health.
- Detailed guidelines are provided around the registration of new drugs, generic drugs, medical devices and other regulated products in Brazil according to ANVISA's
ANVISA is the Brazilian Health Surveillance Agency that regulates health products and services. It oversees the registration, labeling, and safety monitoring of drugs, medical devices, cosmetics, food, and other products. ANVISA also regulates blood and tissue donation, health services, pesticides, and tobacco. It aims to protect public health through rules, inspections, and international cooperation.
Mandala International PDF brochure for Regulatory Affairs, Quality Assurance and Product Registration services for COFEPRIS (Mexico)
Our services:
Product Registration; License Holding
GMP Certification; Quality Assurance
Pharmacovigilance
GAP Analysis
Distributor Search; Market Research; Business Development
Mandala International is world's leading company for COFEPRIS (Mexico) Product Registration.
For more information email me at: david.ortega@mandala-intl.com
The National Health Surveillance Agency (ANVISA) was established in 1999 in Brazil to coordinate various national health programs and oversee sanitary control and surveillance. ANVISA monitors drug prices, medical devices, tobacco products and more. It aims to protect public health by regulating products and services subject to health oversight. ANVISA is part of the National System of Sanitary Surveillance, which works to inspect professional activities and places that handle food and more. ANVISA's responsibilities include oversight of areas like blood, cosmetics, drugs, food, laboratories and more to help ensure health and safety.
Establishment, organization and the role of EFMHACAkidane Michael
Health services and products are the most stringently regulated in the world.
The current regulation represents the distilled wisdom of past experiences.
Having safe and quality products and services is a corner stone for public health
Ethiopian Food, Medicine and Healthcare Administration and Control Authority was established since 2010. IT replaces the former DACA; which was responsible to regulate medicine only.
EFMHACA is a federal science based law enforcement authority mandated to protect the public health and safety
Established by Council of Ministers Regulation No. 189/2010
Established as an autonomous government office having its own legal personality
Accountable to Ministry of Health
Head office at Addis Ababa and may have branch office else where, as may be necessary
Objectives
To protect the health of consumers by ensuring:
Food safety and quality
Safety, efficacy, quality and proper use of medicines
Competence and ethics of health professionals
The standards of health institution and
The hygiene and environmental health protection suitability for individuals and community health
Mission Statement
To promote and protect the public health by ensuring safety and quality of products and health service through
registration, licensing and inspection of health professionals, pharmaceuticals & food establishments, and health facilities and
provision of up-to-date regulatory information
promoting rational medicines use
Organized regulation started since 1960s
Health Sector Reform [in 2008]; which scrutinizes all regulatory components together
Mandate were divided into [in 2009)
Federal regulatory body
Regional regulatory bodies
The Federal Agency for Medicines and Health Products (FAMHP) is the competent authority responsible for the quality, safety and efficacy of medicines and health products in Belgium. It ensures medicines and health products are authorized and used properly from development through post-marketing. Key activities include clinical trial authorization, marketing authorization, production inspections, pharmacovigilance, and ensuring proper use. Applicants can request scientific-technical advice from FAMHP to facilitate drug development and availability of innovative treatments for patients. Advice requests require supporting documentation and a fee and are reviewed within defined timelines depending on type.
This document discusses natural health products (NHPs) in Canada, including regulatory requirements and market opportunities. NHPs include vitamins, minerals, herbal remedies, probiotics, and other supplements. Health Canada regulates NHPs through product licensing, site licensing, and good manufacturing practices. There are three classes of NHPs with different approval pathways and timelines. While Canada has a large NHP market and export opportunities due to Health Canada's reputation, herbal medicines face challenges due to variability and innovation is limited for Class I and II products. A SWOT analysis identifies strengths, weaknesses, opportunities and threats for the Canadian NHP industry.
Latest update Brazil Regulations By S. Jaime - Qserve Group (Qserve Conferen...qserveconference2013
The document discusses regulations for medical devices in Brazil, including the country's healthcare system and regulatory approval process. It outlines key steps such as classification, appointing a Brazilian registration holder, ANVISA GMP inspection, INMETRO certification, and ANVISA registration. The lengthy overall process and importance of understanding regulatory changes and working with a local partner are emphasized.
This document provides information about ANVISA, the National Health Surveillance Agency of Brazil. Some key points:
- ANVISA is the regulatory body that oversees pharmaceuticals, cosmetics, medical devices and other health products in Brazil. It was established in 1999.
- ANVISA's mission is to protect and promote public health by ensuring safety and quality standards for products and services.
- It is responsible for monitoring drug prices, medical device approval, tobacco control and more. ANVISA works with the Brazilian Ministry of Health.
- Detailed guidelines are provided around the registration of new drugs, generic drugs, medical devices and other regulated products in Brazil according to ANVISA's
ANVISA is the Brazilian Health Surveillance Agency that regulates health products and services. It oversees the registration, labeling, and safety monitoring of drugs, medical devices, cosmetics, food, and other products. ANVISA also regulates blood and tissue donation, health services, pesticides, and tobacco. It aims to protect public health through rules, inspections, and international cooperation.
Mandala International PDF brochure for Regulatory Affairs, Quality Assurance and Product Registration services for COFEPRIS (Mexico)
Our services:
Product Registration; License Holding
GMP Certification; Quality Assurance
Pharmacovigilance
GAP Analysis
Distributor Search; Market Research; Business Development
Mandala International is world's leading company for COFEPRIS (Mexico) Product Registration.
For more information email me at: david.ortega@mandala-intl.com
The National Health Surveillance Agency (ANVISA) was established in 1999 in Brazil to coordinate various national health programs and oversee sanitary control and surveillance. ANVISA monitors drug prices, medical devices, tobacco products and more. It aims to protect public health by regulating products and services subject to health oversight. ANVISA is part of the National System of Sanitary Surveillance, which works to inspect professional activities and places that handle food and more. ANVISA's responsibilities include oversight of areas like blood, cosmetics, drugs, food, laboratories and more to help ensure health and safety.
Establishment, organization and the role of EFMHACAkidane Michael
Health services and products are the most stringently regulated in the world.
The current regulation represents the distilled wisdom of past experiences.
Having safe and quality products and services is a corner stone for public health
Ethiopian Food, Medicine and Healthcare Administration and Control Authority was established since 2010. IT replaces the former DACA; which was responsible to regulate medicine only.
EFMHACA is a federal science based law enforcement authority mandated to protect the public health and safety
Established by Council of Ministers Regulation No. 189/2010
Established as an autonomous government office having its own legal personality
Accountable to Ministry of Health
Head office at Addis Ababa and may have branch office else where, as may be necessary
Objectives
To protect the health of consumers by ensuring:
Food safety and quality
Safety, efficacy, quality and proper use of medicines
Competence and ethics of health professionals
The standards of health institution and
The hygiene and environmental health protection suitability for individuals and community health
Mission Statement
To promote and protect the public health by ensuring safety and quality of products and health service through
registration, licensing and inspection of health professionals, pharmaceuticals & food establishments, and health facilities and
provision of up-to-date regulatory information
promoting rational medicines use
Organized regulation started since 1960s
Health Sector Reform [in 2008]; which scrutinizes all regulatory components together
Mandate were divided into [in 2009)
Federal regulatory body
Regional regulatory bodies
The Federal Agency for Medicines and Health Products (FAMHP) is the competent authority responsible for the quality, safety and efficacy of medicines and health products in Belgium. It ensures medicines and health products are authorized and used properly from development through post-marketing. Key activities include clinical trial authorization, marketing authorization, production inspections, pharmacovigilance, and ensuring proper use. Applicants can request scientific-technical advice from FAMHP to facilitate drug development and availability of innovative treatments for patients. Advice requests require supporting documentation and a fee and are reviewed within defined timelines depending on type.
This document discusses natural health products (NHPs) in Canada, including regulatory requirements and market opportunities. NHPs include vitamins, minerals, herbal remedies, probiotics, and other supplements. Health Canada regulates NHPs through product licensing, site licensing, and good manufacturing practices. There are three classes of NHPs with different approval pathways and timelines. While Canada has a large NHP market and export opportunities due to Health Canada's reputation, herbal medicines face challenges due to variability and innovation is limited for Class I and II products. A SWOT analysis identifies strengths, weaknesses, opportunities and threats for the Canadian NHP industry.
The Natural Health Products Regulations came into force in 2004 to regulate natural health products in Canada. As part of ongoing review of the regulations, guidance documents have been created to help industry comply and stakeholders can check for licensed products by looking for the eight-digit Natural Product Number on labels. The review aims to modernize regulations while ensuring Canadians have access to safe, effective natural health products.
The Ministry of Health and Social Protection of Colombia passed Resolution XX of 2014 to increase transparency regarding relationships between actors in the health sector and the pharmaceutical industry. It establishes a two-stage process for mandatory registration of payments from pharmaceutical companies to health professionals, organizations, and institutions. The first stage requires voluntary reporting of aggregate payment amounts. The second stage mandates identifying individual recipients to allow analysis of potential influences on prescribing decisions and costs. The resolution aims to promote rational drug use and address conflicts of interest through public disclosure.
This document outlines guidelines for filing applications using an Integrated Application Form adopted by the Philippines' Food and Drug Administration (FDA) to streamline the application process. The form was created to comply with laws mandating improved efficiency and accountability in government services. It consolidates requirements for various FDA authorizations like licenses and permits onto a single electronic form. Applicants must submit documentary requirements digitally, pay fees, and provide hard copies of certain documents to complete the application process based on a scheduled intake procedure.
Very good pmda 介紹上市後監督(英文)-s401 03 tomoko okudaira才雄 呂
1) The document discusses pharmacovigilance practices in Japan, including an overview of the Pharmaceuticals and Medical Devices Agency (PMDA) and its role in post-marketing safety activities.
2) Key post-marketing activities discussed include good vigilance practice (GVP), adverse drug reaction (ADR) reporting, early post-marketing phase vigilance (EPPV), and drug re-examination.
3) Risk management strategies used in Japan are also summarized, such as risk communication tools, managed drug distribution programs, and the Thalidomide risk management system as an example.
This document establishes the Food and Drug Administration (FDA) in the Philippines to regulate and ensure the safety of foods, drugs, and cosmetics. It creates the FDA under the Department of Health and gives it responsibilities like establishing standards, inspecting products, and enforcing laws. It also forms a Board of Food and Drug Inspection to advise the FDA and conduct investigations. The FDA was later abolished and replaced by the Bureau of Food and Drugs, which assumed its functions and additional responsibilities like monitoring product advertising claims.
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
This document provides an overview of the key drug laws in Pakistan, including the Drugs Act of 1976, rules framed under the Act, the DRAP Act of 2012, and the Pharmacy Act of 1967. It summarizes the purpose and some important sections of each law. The Drugs Act regulates drug import, manufacture, storage, distribution and sale. It establishes various regulatory bodies and sets penalties for violations. The rules framed under the Act cover licensing, registration, advertising and other areas. The DRAP Act established the Drugs Regulatory Authority of Pakistan and regulates biologicals, drugs, medical devices and other therapeutic goods. The Pharmacy Act established pharmacy councils and regulates the profession of pharmacy.
- Mexico has a $1.177 trillion GDP and annual growth rate of 3.9% in 2012 and projected 3.5% in 2013, with services accounting for 70% of GDP.
- The pharmaceutical industry in Mexico accounts for 1.2% of GDP and 6.9% of manufacturing GDP, with annual exports of $2.2 billion and a total market of $13 billion. The industry employs over 78,500 directly and 330,000 indirectly.
- COFEPRIS is the Mexican health authority that regulates the pharmaceutical, medical device, and healthcare industries, representing a $92 billion market. It oversees all aspects of the supply chain from production to advertising.
Contents:
History
DRAP
Composition of DRAP
Function of DRAP
Policy board
Funds and budget of DRAP
Real picture of DRAP
Other agencies
References
History Of Authorities
What Is Drug Regulatory Authority
Drug Regulatory Authority of Pakistan (DRAP) has been established in NOV13,2012 for effective coordination and enforcement of the Drugs Act, 1976.
The Drug Regulatory Authority of Pakistan (DRAP) is an autonomous body working under the administrative control of Ministry of National Health Services.
The Authority is expected to regulate, manufacture, import, export, storage, distribution and sale of therapeutic goods.
What Is Drug Regulatory Authority,…
The authority may set up its establishments including sub-offices and laboratories at province capital and such other places from time to time.
The existing Federal Drug Control Administration(FDCA) and sub offices set up in all provinces are called Central Drug Laboratory
For example;
National Control Laboratory on Biological, Karachi
Federal Drug Surveillance Laboratory, Islamabad
Composition Of DRAP
Chief executive officer
Director Pharmaceutical Evaluations and Registration
Director Drug Licensing
Director Quality Assurance and Laboratory Testing
Director Medical Devices and Medicated Cosmetics
Director Biological Drugs
Composition Of DRAP,….
Director Controlled Drugs
Director Health and OTC Products (non-drugs)
Director Costing and Pricing
Director Budget and Accounts
Director Administration, Human Resource and Logistics
Director Legal Affairs
Director Management Information Services
Power And Function Of DRAP
Evaluation and Registration of pharmaceutical drugs, medical devices and medicated cosmetics, alternative medicines And Licensing of Drug Manufacturing facilities.
Regulation of controlled drugs and biological drugs.
Policy board
DRA will work under the Policy board which consists of 15 members.
Chair person of Board will be Secretary of Federal Health Division
Members will consist of Chief Executive of Agency, Health Secretary of all provinces.
Functions of policy board
Monitor and supervise all function of the DRAP.
Approve the budget of the DRAP.
Determine all fees and leaves.
Funds And Budgets
Loans and grants from the national and international agencies received by the federal government and provincial government to finance the function of the authority.
Grat-in aid in term of salaries and retirements benefits of the existing staff provided by the federal government.
Charges and fees collected by the authority to recover the cost of regulated activities
Funds And Budgets……………
Central research fund collected from pharmaceutical industry.
The authority shall, in respect of each financial year prepare an annual budget for approval from board and shall sent to the federal government for appropriate provision and allocation.
Facts About DRAP
Dr Hussein, regional
This syllabus covers Pharmaceutical Jurisprudence for the second year of a D. Pharm program. It will examine the origin and evolution of pharmaceutical legislation in India, including the Pharmacy Act of 1948, the Drugs and Cosmetics Act of 1940, the Drugs and Magic Remedies Act of 1954, and the Narcotic Drugs and Psychotropic Substances Act of 1985. Key topics include the regulation of pharmacy education and practice, drug licensing, labeling, and storage requirements. Professional ethics for pharmacists will also be discussed.
Compliance in cross border pharmaceutical tradeRemi ADESEUN
The role of compliance in pharmaceutical cross-border trade is discussed. Compliance involves ensuring goods entering a country conform to all laws and regulations, and is a focus for regulators like NAFDAC in Nigeria and customs services. NAFDAC's role includes inspecting and certifying imported and exported pharmaceuticals to control quality and prevent non-compliant trade. Harmonization of regulatory standards across countries can help increase legitimate cross-border pharmaceutical trade in Africa by improving efficiency and reducing costs.
This document provides an overview of the administration of the Drugs and Cosmetics Act and Rules in India. It discusses the roles of various analytical, executive, and advisory bodies involved in drug regulation. It also outlines the qualifications, duties, and powers of key regulatory positions like Government Analysts, Drugs Inspectors, and the procedures they follow to inspect facilities, collect samples, test drugs, and take action if drugs are found to be substandard.
This Powerpoint covers the most Frequently asked Questions in Pharmaceutical Jurisprudence for Pharmacy Students.
The slides cover all the topics that are in the Syllabus for D. Pharmacy students
There are some basic laws which are to be followed by every profession. Most of the Ayurveda professional are not aware about these legal points. These includes- Conduct& Etiquette, ethics, advertisements, manufacturing of medicine for own patients, clinical registration act 2012, insurance and ayurveda, Bio-medical waste etc.
The document discusses Kenya's efforts to strengthen regulation of medical devices and in vitro diagnostics (IVDs) to support universal health coverage. It outlines Kenya's regulatory system, including new guidelines for medical device registration and an online portal for submissions. A phased implementation approach is proposed, beginning with higher risk devices. International harmonization is emphasized to facilitate access while ensuring safety. The timeline targets public use of the online system and initial registrations in early 2019.
This document provides information about a welcome address given by Dr. B. L. Meena, Director General of Drugs Control Administration in Andhra Pradesh, to foreign regulatory delegates attending BioAsia-2013. It discusses the roles and functions of the Central Drugs Standard Control Organization and the Andhra Pradesh Drugs Control Administration in regulating drugs and cosmetics. It also provides details about the licensing process, GMP compliance, inspection and enforcement activities carried out to ensure quality and safety of drugs in India.
The document summarizes key aspects of the Pharmacy Act and Pharmacy Council of India (PCI). It discusses that the Pharmacy Act established the PCI to regulate pharmacy education and practice in India. The PCI frames Education Regulations to set minimum standards for pharmacy qualifications and approves courses and institutions. It also maintains the Central Register of pharmacists. State Pharmacy Councils are constituted to handle registration of pharmacists at the state level. The document outlines qualifications and processes for registration as a pharmacist in India.
ANVISA is the Brazilian Health Surveillance Agency established in 1999 to coordinate the National Sanitary Surveillance System and other health programs. It is responsible for regulating drugs, medical devices, food, cosmetics and other products. ANVISA monitors prices, conducts inspections, and provides technical support. It aims to protect public health through sanitary control of production, marketing and borders. ANVISA is part of the decentralized National System of Sanitary Surveillance and works with various federal, state and municipal agencies.
ANVISA is the regulatory body for health surveillance in Brazil. It was established in 1999 to protect public health by regulating products and services under health surveillance. ANVISA's mission is to protect and promote health by ensuring hygiene, safety of products and services, and facilitating access. The agency is responsible for surveillance of areas like drugs, cosmetics, food, medical devices, and more. It coordinates the National Health Surveillance System and establishes standards. ANVISA's website provides information on regulations, registered products, permits and more.
The Natural Health Products Regulations came into force in 2004 to regulate natural health products in Canada. As part of ongoing review of the regulations, guidance documents have been created to help industry comply and stakeholders can check for licensed products by looking for the eight-digit Natural Product Number on labels. The review aims to modernize regulations while ensuring Canadians have access to safe, effective natural health products.
The Ministry of Health and Social Protection of Colombia passed Resolution XX of 2014 to increase transparency regarding relationships between actors in the health sector and the pharmaceutical industry. It establishes a two-stage process for mandatory registration of payments from pharmaceutical companies to health professionals, organizations, and institutions. The first stage requires voluntary reporting of aggregate payment amounts. The second stage mandates identifying individual recipients to allow analysis of potential influences on prescribing decisions and costs. The resolution aims to promote rational drug use and address conflicts of interest through public disclosure.
This document outlines guidelines for filing applications using an Integrated Application Form adopted by the Philippines' Food and Drug Administration (FDA) to streamline the application process. The form was created to comply with laws mandating improved efficiency and accountability in government services. It consolidates requirements for various FDA authorizations like licenses and permits onto a single electronic form. Applicants must submit documentary requirements digitally, pay fees, and provide hard copies of certain documents to complete the application process based on a scheduled intake procedure.
Very good pmda 介紹上市後監督(英文)-s401 03 tomoko okudaira才雄 呂
1) The document discusses pharmacovigilance practices in Japan, including an overview of the Pharmaceuticals and Medical Devices Agency (PMDA) and its role in post-marketing safety activities.
2) Key post-marketing activities discussed include good vigilance practice (GVP), adverse drug reaction (ADR) reporting, early post-marketing phase vigilance (EPPV), and drug re-examination.
3) Risk management strategies used in Japan are also summarized, such as risk communication tools, managed drug distribution programs, and the Thalidomide risk management system as an example.
This document establishes the Food and Drug Administration (FDA) in the Philippines to regulate and ensure the safety of foods, drugs, and cosmetics. It creates the FDA under the Department of Health and gives it responsibilities like establishing standards, inspecting products, and enforcing laws. It also forms a Board of Food and Drug Inspection to advise the FDA and conduct investigations. The FDA was later abolished and replaced by the Bureau of Food and Drugs, which assumed its functions and additional responsibilities like monitoring product advertising claims.
At the end of the 19th century and early 20 century use of Allopathy system increases
Drugs of natural origin: Veg, mineral oil and animals
At that time, profit became main motive than service
Overdose of quinine.A Central law to control drugs and pharmacy profession.
This document provides an overview of the key drug laws in Pakistan, including the Drugs Act of 1976, rules framed under the Act, the DRAP Act of 2012, and the Pharmacy Act of 1967. It summarizes the purpose and some important sections of each law. The Drugs Act regulates drug import, manufacture, storage, distribution and sale. It establishes various regulatory bodies and sets penalties for violations. The rules framed under the Act cover licensing, registration, advertising and other areas. The DRAP Act established the Drugs Regulatory Authority of Pakistan and regulates biologicals, drugs, medical devices and other therapeutic goods. The Pharmacy Act established pharmacy councils and regulates the profession of pharmacy.
- Mexico has a $1.177 trillion GDP and annual growth rate of 3.9% in 2012 and projected 3.5% in 2013, with services accounting for 70% of GDP.
- The pharmaceutical industry in Mexico accounts for 1.2% of GDP and 6.9% of manufacturing GDP, with annual exports of $2.2 billion and a total market of $13 billion. The industry employs over 78,500 directly and 330,000 indirectly.
- COFEPRIS is the Mexican health authority that regulates the pharmaceutical, medical device, and healthcare industries, representing a $92 billion market. It oversees all aspects of the supply chain from production to advertising.
Contents:
History
DRAP
Composition of DRAP
Function of DRAP
Policy board
Funds and budget of DRAP
Real picture of DRAP
Other agencies
References
History Of Authorities
What Is Drug Regulatory Authority
Drug Regulatory Authority of Pakistan (DRAP) has been established in NOV13,2012 for effective coordination and enforcement of the Drugs Act, 1976.
The Drug Regulatory Authority of Pakistan (DRAP) is an autonomous body working under the administrative control of Ministry of National Health Services.
The Authority is expected to regulate, manufacture, import, export, storage, distribution and sale of therapeutic goods.
What Is Drug Regulatory Authority,…
The authority may set up its establishments including sub-offices and laboratories at province capital and such other places from time to time.
The existing Federal Drug Control Administration(FDCA) and sub offices set up in all provinces are called Central Drug Laboratory
For example;
National Control Laboratory on Biological, Karachi
Federal Drug Surveillance Laboratory, Islamabad
Composition Of DRAP
Chief executive officer
Director Pharmaceutical Evaluations and Registration
Director Drug Licensing
Director Quality Assurance and Laboratory Testing
Director Medical Devices and Medicated Cosmetics
Director Biological Drugs
Composition Of DRAP,….
Director Controlled Drugs
Director Health and OTC Products (non-drugs)
Director Costing and Pricing
Director Budget and Accounts
Director Administration, Human Resource and Logistics
Director Legal Affairs
Director Management Information Services
Power And Function Of DRAP
Evaluation and Registration of pharmaceutical drugs, medical devices and medicated cosmetics, alternative medicines And Licensing of Drug Manufacturing facilities.
Regulation of controlled drugs and biological drugs.
Policy board
DRA will work under the Policy board which consists of 15 members.
Chair person of Board will be Secretary of Federal Health Division
Members will consist of Chief Executive of Agency, Health Secretary of all provinces.
Functions of policy board
Monitor and supervise all function of the DRAP.
Approve the budget of the DRAP.
Determine all fees and leaves.
Funds And Budgets
Loans and grants from the national and international agencies received by the federal government and provincial government to finance the function of the authority.
Grat-in aid in term of salaries and retirements benefits of the existing staff provided by the federal government.
Charges and fees collected by the authority to recover the cost of regulated activities
Funds And Budgets……………
Central research fund collected from pharmaceutical industry.
The authority shall, in respect of each financial year prepare an annual budget for approval from board and shall sent to the federal government for appropriate provision and allocation.
Facts About DRAP
Dr Hussein, regional
This syllabus covers Pharmaceutical Jurisprudence for the second year of a D. Pharm program. It will examine the origin and evolution of pharmaceutical legislation in India, including the Pharmacy Act of 1948, the Drugs and Cosmetics Act of 1940, the Drugs and Magic Remedies Act of 1954, and the Narcotic Drugs and Psychotropic Substances Act of 1985. Key topics include the regulation of pharmacy education and practice, drug licensing, labeling, and storage requirements. Professional ethics for pharmacists will also be discussed.
Compliance in cross border pharmaceutical tradeRemi ADESEUN
The role of compliance in pharmaceutical cross-border trade is discussed. Compliance involves ensuring goods entering a country conform to all laws and regulations, and is a focus for regulators like NAFDAC in Nigeria and customs services. NAFDAC's role includes inspecting and certifying imported and exported pharmaceuticals to control quality and prevent non-compliant trade. Harmonization of regulatory standards across countries can help increase legitimate cross-border pharmaceutical trade in Africa by improving efficiency and reducing costs.
This document provides an overview of the administration of the Drugs and Cosmetics Act and Rules in India. It discusses the roles of various analytical, executive, and advisory bodies involved in drug regulation. It also outlines the qualifications, duties, and powers of key regulatory positions like Government Analysts, Drugs Inspectors, and the procedures they follow to inspect facilities, collect samples, test drugs, and take action if drugs are found to be substandard.
This Powerpoint covers the most Frequently asked Questions in Pharmaceutical Jurisprudence for Pharmacy Students.
The slides cover all the topics that are in the Syllabus for D. Pharmacy students
There are some basic laws which are to be followed by every profession. Most of the Ayurveda professional are not aware about these legal points. These includes- Conduct& Etiquette, ethics, advertisements, manufacturing of medicine for own patients, clinical registration act 2012, insurance and ayurveda, Bio-medical waste etc.
The document discusses Kenya's efforts to strengthen regulation of medical devices and in vitro diagnostics (IVDs) to support universal health coverage. It outlines Kenya's regulatory system, including new guidelines for medical device registration and an online portal for submissions. A phased implementation approach is proposed, beginning with higher risk devices. International harmonization is emphasized to facilitate access while ensuring safety. The timeline targets public use of the online system and initial registrations in early 2019.
This document provides information about a welcome address given by Dr. B. L. Meena, Director General of Drugs Control Administration in Andhra Pradesh, to foreign regulatory delegates attending BioAsia-2013. It discusses the roles and functions of the Central Drugs Standard Control Organization and the Andhra Pradesh Drugs Control Administration in regulating drugs and cosmetics. It also provides details about the licensing process, GMP compliance, inspection and enforcement activities carried out to ensure quality and safety of drugs in India.
The document summarizes key aspects of the Pharmacy Act and Pharmacy Council of India (PCI). It discusses that the Pharmacy Act established the PCI to regulate pharmacy education and practice in India. The PCI frames Education Regulations to set minimum standards for pharmacy qualifications and approves courses and institutions. It also maintains the Central Register of pharmacists. State Pharmacy Councils are constituted to handle registration of pharmacists at the state level. The document outlines qualifications and processes for registration as a pharmacist in India.
ANVISA is the Brazilian Health Surveillance Agency established in 1999 to coordinate the National Sanitary Surveillance System and other health programs. It is responsible for regulating drugs, medical devices, food, cosmetics and other products. ANVISA monitors prices, conducts inspections, and provides technical support. It aims to protect public health through sanitary control of production, marketing and borders. ANVISA is part of the decentralized National System of Sanitary Surveillance and works with various federal, state and municipal agencies.
ANVISA is the regulatory body for health surveillance in Brazil. It was established in 1999 to protect public health by regulating products and services under health surveillance. ANVISA's mission is to protect and promote health by ensuring hygiene, safety of products and services, and facilitating access. The agency is responsible for surveillance of areas like drugs, cosmetics, food, medical devices, and more. It coordinates the National Health Surveillance System and establishes standards. ANVISA's website provides information on regulations, registered products, permits and more.
Japan PMDA Medical Device Regulatory Approval ProcessEMERGO
Watch the recorded webinar: https://www.emergogroup.com/resources/video-webinar-japan-registration-process
Japan's medical device market is one of the most robust markets in Asia, but its regulatory system can be confusing. Before deciding to sell your device in the Japanese market, it is important to understand how the regulations apply to your device, which steps to take, and what resources are required to complete the process. In this presentation, Ann Marie Boullie, Vice President of Business Development for EMERGO, will discuss some of the most complex aspects of the Japanese registration process, including:
JMDN codes: device classification and predicates
Clinical data requirements and PMDA pre-submission meetings
Registration routes (Todokede, Ninsho, Shonin)
QMS (Ordinance 169) requirements
Role of the Marketing Authorization Holder (MAH)
Plus more ...
Webinar: Europe's new Medical Device Regulations (MDR)EMERGO
WATCH the recorded webinar here: http://www.emergogroup.com/resources/video-webinar-europe-mdr-changes
The first major revision to device regulations since 2007 has been released and the changes are significant. Although the MDR won't take effect until early 2020, smart companies are planning ahead to beat the crush of companies that will inevitably wait until the last minute, overwhelming EU Notified Bodies. Ronald Boumans, Senior Global Regulatory Consultant for EMERGO (and former IGZ compliance inspector in The Netherlands) outlines the most important changes you need to know in this 35 minute recorded webinar from September 2016. Topics addressed include:
How the MDR is organized
Scope of the legislation
Device classification rules
New clinical evaluation requirements
UDI and EUDAMED database
Adverse event reporting
And much more...
The Japanese market for medical devices reached $37.6 billion in 2016 and is expected to grow to $45 billion by 2020, making it the second largest market globally in terms of growth rate. It remains heavily reliant on imports, especially for sophisticated devices. The regulatory agencies overseeing the medical device market in Japan are the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labor and Welfare (MHLW). Devices are classified based on risk into four classes, with Class I having the lowest risk and Class IV the highest. Regulatory approval processes differ depending on the class, ranging from self-declaration for Class I devices to pre-market approval from MHLW for Class III and
Latin America: Challenges & Opportunities in Clinical ResearchMedpace
With an established regulatory environment and a strong healthcare infrastructure, Latin America continues to grow as an advantageous landscape for conducting clinical research. Join Medpace experts Anibal Calmaggi, MD, Senior Medical Director, Infectious Diseases and Vaccines, and Wanda Dobrzanski, MD, Director Clinical Operations, Pediatric infectious diseases and Pharmaceutical medicine specialist, as they share their collective 36 years of experience in designing and managing clinical research in Latin America.
This presentation discusses:
• Advantages and benefits of running trials in Latin America
• Challenges and strategies for addressing them
• Required procedures and processes
• An in-depth look at the most significant Latin American countries for conducting clinical research
Clinipace worldwide: Conducting Clinical Trials in Latin Americaguestc74e8c36
The document discusses conducting clinical trials in Latin America. It provides an overview of key considerations for investigators, sites, patients, the regulatory environment, and common challenges and suggestions for success. Specific topics covered include investigator experience and training, public vs private sites and locations, patient standards of care, epidemiology, regulatory timelines and processes, informed consent requirements, and regional requirements regarding comparators and continued treatment.
Latin America provides opportunities for clinical research due to its large, diverse population concentrated in major cities. The region has two main languages and a growing pharmaceutical market projected to reach $80 billion by 2013. Countries like Brazil, Argentina, and Chile form the large Southern Cone market and have quality clinical research environments with experienced regulators following ICH-GCP guidelines. However, some challenges remain like improving ethics review, dedicated research infrastructure, and lengthy government approval processes. Overall, Latin America's lower costs and unique patient populations make it an attractive region for recruitment in clinical trials.
La Comunidad Andina de Naciones (CAN) es una organización formada por Bolivia, Colombia, Ecuador y Perú con el objetivo de lograr un desarrollo más equilibrado e integrado entre sus países miembros. El documento analiza varios indicadores logísticos y de transporte terrestre y marítimo entre Colombia y los demás países de la CAN.
Netherland medical devices compliance update Erik Vollebregt
The document summarizes recent developments regarding compliance with regulations on interactions between the medical device industry and healthcare professionals in the Netherlands. Specifically, it discusses:
1) An agreement by hospitals and doctors' associations to comply with the Dutch code on gifts and hospitality from industry, though some professional groups have not agreed yet.
2) The Dutch government lobbying for stronger enforcement tools regarding healthcare professional interactions in proposed EU regulations, but it is unclear if this will be included.
3) Planned amendments to Dutch law to allow the competent authority to enforce regulations on industry gifts and hospitality, analogous to rules for pharmaceutical companies. The changes could take effect in 2016.
Clinical research in Latin America: constraints and opportunitiesCER Clinical Trials
The number of patients enrolled in international multi-centre clinical trials has increased in some countries of Latin America. Eduardo Gotuzzo, M.D. FACP
The document provides an overview of Japan's regulatory system for pharmaceutical products. It discusses the classification of medical products, the required licenses to manufacture and market products, and the roles of the Ministry of Health and Pharmaceuticals and Medical Devices Agency. It also summarizes regulations around clinical trials, marketing approval, pricing, manufacturing, advertising, packaging, patents, trademarks, and product liability.
Clinical trials in Latin America face regulatory frameworks that vary by country. While countries like Argentina, Brazil, and Mexico have adopted international good clinical practice guidelines, regulatory approval processes can be lengthy, requiring documents translated to the local language and approvals from both local and national ethics boards. Common challenges include economic instability, intellectual property protection, and health care access and costs. Strategies for successful clinical trials in the region include early planning, partnering with experienced local clinical research organizations, and consulting regulatory experts from within each country.
Taiwan medical device registration and approval chart - EMERGOEMERGO
Taiwan regulates medical devices through the Pharmaceutical Affairs Act and Regulations for Governing the Management of Medical Devices. The process involves classifying the device, appointing a Taiwan agent, preparing quality system documentation for submission, and obtaining approval. Device classification and complexity of approval requirements vary, with Class I generally having the simplest process taking 1-2 months, Class II taking 10-12 months, and Class III taking 10-12 months and requiring a committee review.
Mexico has a large pharmaceutical market worth $13 billion. COFEPRIS is the regulatory authority that oversees drug approval and GMP inspections. Drug registration requires extensive documentation and can take 12-24 months. Local clinical trials may be required. New detailed regulations were introduced in 2012 to regulate biologics and biosimilars. GMP inspections by COFEPRIS of manufacturing sites are required for new drug approvals and changes and can take around 3 months to arrange.
Saudi arabia medical device regulatory processEMERGO
To market medical devices in Saudi Arabia, devices must receive marketing authorization from the Saudi Food and Drug Authority (SFDA). The SFDA application is reviewed for completeness then sent to a third party for technical review, which can involve multiple rounds of questions. Once approved, the SFDA issues a certificate allowing marketing in Saudi Arabia. Appointing an authorized local representative is also required to manage the registration process. Overall, registration times range from 1-6 months but costs and complexity vary depending on the device's risk classification.
Brazil medical device registration and approval chart - EMERGOEMERGO
Brazil has a classification system for medical devices with four classes - I, II, III, and IV. Class I and II devices require a simplified registration called a Cadastro, while Class III and IV devices require a more rigorous registration called a Registro. To register a device, a company must appoint a Brazil Registration Holder to submit the application to ANVISA and obtain necessary approvals. Certain devices may also require certification from inspection agency INMETRO. The registration process can take 1-3 months for Classes I and II or 8-15 months for Classes III and IV, though Class III and IV can take over 4 years if additional inspections are required.
This document describes a company that offers various plans to help foreign companies sell products in Brazil. They provide a sales platform, virtual offices in Sao Paulo, and a warehouse in China. Their plans include services like product registration, marketing, logistics, and customer support. Prices for the plans range from $4,500 to $10,500 per month. The company aims to help foreign businesses enter the Brazilian market quickly with low costs and investment.
If you are one of those who decided to open your own cannabis dispensary, note that it is essential to create a detailed business plan. Not only is it a crucial tool when it comes to raising capital, it also ensures strategic guidance covering every aspect of ownership from preparation to operations.
This document summarizes growth consulting services provided by Generic Pharma 2.0 for international market entry. They offer a 4 step process including market analysis, planning, engagement, and operations. They have experts located around the world and provide case studies and strategies for specific markets like Latin America, Brazil, Argentina, USA, and China.
THIS PRESENTATION IS MADE FOR YOU IF YOUR COMPANY FACES ONE OF THESE TWO SCENARIOS:
“WE SUCCESSFULLY STARTED SELLING IN BRAZIL,
BUTTHENUMBERS ARE DISAPPOINTING.WE´VE BEEN
TRYING NEW STUFF BUT STILL DIDN’T GET REAL TRACTION”
”WE KNOW THAT EXPANDING TO NEW MARKETS IS THE NEXT BIG
THING. BUT TO BE HONEST IT SEEMS TOO RISKY. WE DON´T KNOW
ENOUGH ABOUT DOING BUSINESS IN BRAZIL.”
The document discusses establishing a Representative Office in Curitiba, Brazil to help foreign companies access the Brazilian market. It outlines Brazil's strong economy and consumer spending power. Establishing a Representative Office would provide business address, start-up assistance, office management, marketing/sales support, and help with governmental affairs like registrations and permits. Services are offered on an exclusive annual fee basis, with the fee applying towards future commissions. Assistance is also offered for governmental meetings and presentations through public relations and translation support.
Brazil is an attractive market for telecommunications companies due to its growing middle class, increasing internet usage, and large economy. The telecom market in Brazil reached $99 billion in 2014 and is forecast to reach $120 billion by 2017. There are five main operators in the fixed-line sector and four that control 97% of the mobile market. Companies looking to enter the Brazilian market should develop personal relationships, attend trade shows, and work with consulting companies that specialize in the Latin American market to help navigate Brazil's complex legal and tax systems. A long-term strategy based on research and local partnerships is recommended to successfully break into the Brazilian telecom industry.
This document summarizes the services of a business development and marketing agency called Generic Pharma 2.0. They help generic pharmaceutical companies grow their business through customized business development plans, proprietary marketing networks, and access to opportunities. They have experience in over-the-counter drugs, biosimilars, and consulting. Their services include lead generation, business development, digital marketing, printing, and web design to help clients find new revenue opportunities.
Generic Pharma 2.0 Masters of Business Development & MarketingGeneric Pharma 2.0
Introduction to Generic Pharma 2.0
- Business Development Toolkit
- Portfolio Consulting
- Digital Marketing
- Lead Generation & Conversion
- Design & Creative
The document summarizes the experiences of 32 UK small and medium enterprises entering the Brazilian market. It finds that the main problems they encountered were complex regulations and bureaucracy, corruption, language barriers. To address these issues, some firms partnered with Brazilian agents who helped navigate the market, while others avoided risk by doing business through agents in other countries or skirting regulations. The document provides advice on how to succeed in Brazil such as having a competitive product, building relationships, understanding the culture and doing thorough market research. It also discusses how export promotion institutions can better support small firms entering new markets.
Supérame is an international consulting firm that helps companies expand globally through strategic consulting services, international trade facilitation, and legal and marketing support. They have a worldwide network of professionals across industries and offer services including market research, import/export licensing, logistics management, and establishing foreign business entities. Their goal is to provide full-service solutions to help businesses access new international markets.
Garrigues is a leading international law firm based in Spain with offices across Europe and Latin America. It has focused strategically on expanding its presence in Latin America, a natural region for many of its clients. The first phase of expansion included opening new offices in Bogota, Mexico City, and Lima. The firm aims to provide integrated legal services across its regional office network to meet the needs of global clients.
Relatório anual 2012 (eng) melhor resolução (site)brpharma
Brasil Pharma is a leading pharmaceutical retailer in Brazil operating over 1,000 stores across five regional chains and a franchise system. In 2012, Brasil Pharma underwent a process of integrating its regional brands under a single national Brasil Pharma identity and culture. This included launching a new corporate brand and shared services center, restructuring the commercial department, and standardizing store operations. Brasil Pharma's goal is to be the best drugstore chain in Brazil by providing health and well-being to customers, long-term partnerships with suppliers, a good working environment for employees, and profitability for shareholders.
BGMD is a medical device marketing and distribution firm that helps companies sell their products in Latin America and the Caribbean. The $14 billion Latin American medical device market is dominated by Brazil, Mexico, Colombia, Venezuela, and Argentina. BGMD offers distribution networks, marketing strategies, supply chain support, and expertise in areas like endoscopy, surgery, and cardiology to help companies succeed in this diverse region. Led by executives with over 20 years of experience launching medical products in Latin America, BGMD provides clients with knowledge of each local market and regulatory environment.
Giovanni Sarazúa is a trilingual global sales manager with extensive experience in Latin America and Asia. He has over 15 years of experience managing sales teams, developing business, and establishing relationships with key clients. Sarazúa specialized in B2B sales across diverse industries and provides training on topics such as health and safety compliance.
This document summarizes the opportunity to own a tax preparation franchise through Umbrella Financial Services Tax Solutions Group (UFSTSG). UFSTSG offers a low-cost franchise model for tax preparation businesses, requiring no franchise fees or territorial restrictions. They provide training, marketing support, and guidance to help new franchise owners open and grow a profitable tax preparation business. The tax preparation industry remains stable year-round but sees most business during tax season from January to April, allowing owners summer breaks. UFSTSG claims their model can generate over $60,000 in the first tax season with potential for unlimited future earnings growth.
Cloud Kitchen Marketing Ideas to Grow Your Online SalesShamshad Alam
As per the National Restaurant Association, 90% of the restaurants believe that their success is essentially hooked in to their social media marketing style. Social media possesses an undeniable power to influence people’s choices and decisions. On Pinterest for instance, food is that the most browsed and pinned. Using social media platforms like Facebook, Instagram, and Twitter, you'll attract thousands of potential customers.
|| +91 9999008018 || info@corpseed.com || https://bit.ly/2Sm9N4w ||
I Mreport Market Selection (Roll No 6 &7)Radhikachemical
This presentation is on the Market Selection Process. I have chosen body care products to be marketed in the Latin American Countries. In this case, comparison between Brazil & Argentina
BBGLOBALSOLUTIONS provides direct sales and multi-level marketing consulting services globally. They offer market analysis, business plan development, sales channel selection, compensation plan creation, manual development, and software/website support to launch or expand direct sales operations. BBGLOBALSOLUTIONS has experience consulting for companies in various industries and countries around the world.
The document discusses different approaches for growing international sales in Europe, describing traditional methods like distributors and organic growth. It then introduces a new approach called the "Power Landing Zone", which combines the customer relationship advantages of organic growth with the lower costs of distributors. The Power Landing Zone provides a complete sales and marketing platform through a flexible suite of customizable services.
Information About WinBidsPro : WinBidsProwinbidspro
WinBidsPro is a service that has helped small businesses connect with and sell to the government for over 15 years. It provides all the necessary resources in one place to assist companies in navigating the government contracting process. This includes identifying prospective government buyers, researching which bids are most likely to win and why, finding partnership opportunities, accessing the most up-to-date contact leads, and providing training and support from a dedicated client manager to guide businesses.
Similar to Medical Device - ANVISA regulation in Brazil (20)
Tired of chasing down expiring contracts and drowning in paperwork? Mastering contract management can significantly enhance your business efficiency and productivity. This guide unveils expert secrets to streamline your contract management process. Learn how to save time, minimize risk, and achieve effortless contract management.
Prescriptive analytics BA4206 Anna University PPTFreelance
Business analysis - Prescriptive analytics Introduction to Prescriptive analytics
Prescriptive Modeling
Non Linear Optimization
Demonstrating Business Performance Improvement
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART KALYAN CHART
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Niswey
50 million companies worldwide leverage WhatsApp as a key marketing channel. You may have considered adding it to your marketing mix, or probably already driving impressive conversions with WhatsApp.
But wait. What happens when you fully integrate your WhatsApp campaigns with HubSpot?
That's exactly what we explored in this session.
We take a look at everything that you need to know in order to deploy effective WhatsApp marketing strategies, and integrate it with your buyer journey in HubSpot. From technical requirements to innovative campaign strategies, to advanced campaign reporting - we discuss all that and more, to leverage WhatsApp for maximum impact. Check out more details about the event here https://events.hubspot.com/events/details/hubspot-new-delhi-presents-unlocking-whatsapp-marketing-with-hubspot-integrating-messaging-into-your-marketing-strategy/
SATTA MATKA DPBOSS KALYAN MATKA RESULTS KALYAN CHART KALYAN MATKA MATKA RESULT KALYAN MATKA TIPS SATTA MATKA MATKA COM MATKA PANA JODI TODAY BATTA SATKA MATKA PATTI JODI NUMBER MATKA RESULTS MATKA CHART MATKA JODI SATTA COM INDIA SATTA MATKA MATKA TIPS MATKA WAPKA ALL MATKA RESULT LIVE ONLINE MATKA RESULT KALYAN MATKA RESULT DPBOSS MATKA 143 MAIN MATKA KALYAN MATKA RESULTS KALYAN CHART
AI Transformation Playbook: Thinking AI-First for Your BusinessArijit Dutta
I dive into how businesses can stay competitive by integrating AI into their core processes. From identifying the right approach to building collaborative teams and recognizing common pitfalls, this guide has got you covered. AI transformation is a journey, and this playbook is here to help you navigate it successfully.
Cover Story - China's Investment Leader - Dr. Alyce SUmsthrill
In World Expo 2010 Shanghai – the most visited Expo in the World History
https://www.britannica.com/event/Expo-Shanghai-2010
China’s official organizer of the Expo, CCPIT (China Council for the Promotion of International Trade https://en.ccpit.org/) has chosen Dr. Alyce Su as the Cover Person with Cover Story, in the Expo’s official magazine distributed throughout the Expo, showcasing China’s New Generation of Leaders to the World.
Efficient PHP Development Solutions for Dynamic Web ApplicationsHarwinder Singh
Unlock the full potential of your web projects with our expert PHP development solutions. From robust backend systems to dynamic front-end interfaces, we deliver scalable, secure, and high-performance applications tailored to your needs. Trust our skilled team to transform your ideas into reality with custom PHP programming, ensuring seamless functionality and a superior user experience.
Satta matka fixx jodi panna all market dpboss matka guessing fixx panna jodi kalyan and all market game liss cover now 420 matka office mumbai maharashtra india fixx jodi panna
Call me 9040963354
WhatsApp 9040963354
Discover the Beauty and Functionality of The Expert Remodeling Serviceobriengroupinc04
Unlock your kitchen's true potential with expert remodeling services from O'Brien Group Inc. Transform your space into a functional, modern, and luxurious haven with their experienced professionals. From layout reconfiguration to high-end upgrades, they deliver stunning results tailored to your style and needs. Visit obriengroupinc.com to elevate your kitchen's beauty and functionality today.
The Steadfast and Reliable Bull: Taurus Zodiac Signmy Pandit
Explore the steadfast and reliable nature of the Taurus Zodiac Sign. Discover the personality traits, key dates, and horoscope insights that define the determined and practical Taurus, and learn how their grounded nature makes them the anchor of the zodiac.
Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...Adani case
Time and again, the business group has taken up new business ventures, each of which has allowed it to expand its horizons further and reach new heights. Even amidst the Adani CBI Investigation, the firm has always focused on improving its cement business.
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...Herman Kienhuis
Presentation by Herman Kienhuis (Curiosity VC) on developments in AI, the venture capital investment landscape and Curiosity VC's approach to investing, at the alumni event of Amsterdam Business School (University of Amsterdam) on June 13, 2024 in Amsterdam.
2. Latin America Total population : 590,086,590 Pop. Density : 27 per sq/km Total countries : 20 Dependencies : 10 Language : Spanish, Portuguese Time zone : UTC -2 to UTC -8
8. ANVISA Was established in January 26th 1999 with the purpose to foster protection the health of the population by regulating, controlling and inspecting products and services in the medical device field, drugs, cosmetics, food and tobacco. Sanitary control over production and marketing of products and services subject to sanitary surveillance. To authorize the operation of manufacturing, distribution and importing firms. To grant and to withdraw certificates of good manufacturing practice; GMP.
9. Regulatory Alternatives Company Incorporation Brazil Assemble local GMP in Brazil Register ANVISA submit paperwork for ANVISA 24-36 Months 24 Months 6-8 Months Mfg. local GMP in Israel Inspection GMP and INMETRO if needed
10.
11. Why us? Quality We make it better Partnership We make it together Accessibility We make it accessible Efficiency We make it happen
12.
13.
14.
15.
16. Our state of the art site in Ribeirão Preto , Brazil, built with the highest standards of ANVISA and includes sterile rooms, assembly line, warehouse and offices .
17. Your Private Office in South America An option of establishing a marketing and distribution local center, including the employment of a regional sales manager at customer’s direct management and supervision, as part of our infrastructure in Brazil. Reducing marketing expenses. Local business culture. Real-time marketing.